  As the development of new classes of antibiotics slows, bacterial resistance
to existing antibiotics is becoming an increasing problem. A potential solution
is to develop treatment strategies with an alternative mode of action. We
consider one such strategy: anti-adhesion therapy. Whereas antibiotics act
directly upon bacteria, either killing them or inhibiting their growth,
anti-adhesion therapy impedes the binding of bacteria to host cells. This
prevents bacteria from deploying their arsenal of virulence mechanisms, while
simultaneously rendering them more susceptible to natural and artificial
clearance. In this paper, we consider a particular form of anti-adhesion
therapy, involving biomimetic multivalent adhesion molecule (MAM) 7 coupled
polystyrene microbeads, which competitively inhibit the binding of bacteria to
host cells. We develop a mathematical model, formulated as a system of ordinary
differential equations, to describe inhibitor treatment of a Pseudomonas
aeruginosa burn wound infection in the rat. Benchmarking our model against in
vivo data from an ongoing experimental programme, we use the model to explain
bacteria population dynamics and to predict the efficacy of a range of
treatment strategies, with the aim of improving treatment outcome. The model
consists of two physical compartments: the epithelium and the exudate. It is
found that, when effective in reducing the bacterial burden, inhibitor
treatment operates both by preventing bacteria from binding to the epithelium
and by reducing the flux of daughter cells from the epithelium into the
exudate. Our model predicts that inhibitor treatment cannot eliminate the
bacterial burden when used in isolation; however, when combined with regular or
continuous debridement of the exudate, elimination is theoretically possible.
Lastly, we present ways to improve therapeutic efficacy, as predicted by our
mathematical model.
